apomorphine hydrochloride hemihydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
APOMINE Intermittent apomorphine hydrochloride hemihydrate 30mg/3mL injection cartridge
AUST R: 296520
Active ingredients:
apomorphine hydrochloride hemihydrate

Dosage form:
Injection, solution

Sponsor:
Interpharma Pty Ltd

Phone:
+61 2 9976 6876

From
12 Oct 2026
to
21 Oct 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
The sponsor is closely controlling the supply and working to expedite the next shipment.
MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe
AUST R: 129948
Active ingredients:
apomorphine hydrochloride hemihydrate

Dosage form:
Injection, solution

Sponsor:
Stada Pharmaceuticals Australia Pty Ltd

Phone:
1800 791 660

Deletion from market:
01 Oct 2026

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available - MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridge (ARTG 423350). Patients are advised to consult their healthcare professional to discuss alternative treatment options.